Hikma Pharmaceuticals Plc Director/PDMR Shareholding (0011D)

TIDMHIK

RNS Number : 0011D

Hikma Pharmaceuticals Plc

24 March 2014

Hikma Pharmaceuticals PLC - Vesting of 2011 LTIP

LONDON, 24 March 2014: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) announces that the following Persons Discharging Managerial Responsibility ("PDMR") have received conditional share awards which vested on 24 March 2014 under the 2005 Long Term Incentive Plan ("LTIP") and were automatically exercised by operation of the conditional award and vesting process. The exercise price under the LTIP is GBPnil. The persons concerned have retained all the shares exercised.

In accordance with DTR 3.1.2R and s.793 of the Companies Act 2006, Hikma announces that the following transactions took place in London over the Company's Ordinary Shares of 10p each as detailed below.

 
 PDMR            Type of Transaction   Exercised      Date         Price      Shares      Remaining 
                                                                               Disposed    Holding 
--------------  --------------------  -------------  -----------  ---------  ----------  ------------------ 
 Bassam          Vesting of            35,432         24 March     GBP16.23   Nil         503,566 
  Kanaan          LTIP 2011                            2014 
                                        (0.02% ISC)                                        (0.25% ISC) 
--------------  --------------------  -------------  -----------  ---------  ----------  ------------------ 
 Michael         Vesting of            31,776         24 March     GBP16.23   Nil         76,160 
  Raya            LTIP 2011                            2014 
                                        (0.02% ISC)                                        (0.04% ISC) 
--------------  --------------------  -------------  -----------  ---------  ----------  ------------------ 
 Riad Mishlawi   Vesting of            19,067         24 March     GBP16.23   Nil         79,327 
                  LTIP 2011                            2014 
                                        (0.01% ISC)                                        (0.04% ISC) 
--------------  --------------------  -------------  -----------  ---------  ----------  ------------------ 
 Khalid          Vesting of            26,011         24 March     GBP16.23   Nil         196,858 
  Nabilsi         LTIP 2011                            2014 
                                        (0.01% ISC)                                        (0.10% ISC) 
--------------  --------------------  -------------  -----------  ---------  ----------  ------------------

- ENDS -

Enquiries

Peter Speirs +44 20 7399 2760

Company Secretary, Hikma Pharmaceuticals PLC

About Hikma

Hikma Pharmaceuticals PLC is a fast growing pharmaceutical group focused on developing, manufacturing and marketing a broad range of both branded and non-branded generic and in-licensed products. Hikma's operations are conducted through three businesses: "Branded", "Injectables" and "Generics" based primarily in the Middle East and North Africa ("MENA") region, where it is a market leader, the United States and Europe. In 2013, Hikma achieved revenues of $1,365 million and profit attributable to shareholders of $212 million.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSBGGDXIBDBGSS

Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024